DR info

Clinical trials : 13 / Drugs : 19 - (DrugBank : 5) / Drug target genes : 18 - Drug target pathways : 10

Non-dystrophic myotonia syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
114	Non-dystrophic myotonia syndrome
13	Multiple sclerosis/Neuromyelitis optica
86	Pulmonary arterial hypertension
115	Hereditary periodic paralysis
154	Epilepsy with continuous spikes and waves during slow sleep
230	Alveolar hypoventilation syndrome
155	Acquired aphasia with convulsive disorder
225	Congenital nephrogenic diabetes insipidus
90	Retinitis pigmentosa
168	Ehlers-Danlos syndrome
140	Dorabe syndrome
144	Lennox-Gastaut syndrome
193	Prader-Willi syndrome
1	Spinal and bulbar muscular atrophy
156	Rett syndrome
10	Charcot-Marie-Tooth disease
97	Ulcerative colitis
6	Parkinson disease
38	Stevens-Johnson syndrome
256	Muscle glycogenosis
231	Alpha-1-antitrypsin deficiency
127	Frontotemporal lobar degeneration
58	Hypertrophic cardiomyopathy
36	Epidermolysis bullosa
107	Juvenile idiopathic arthritis
298	Hereditary pancreatitis
53	Sjogren syndrome
113	Muscular dystrophy
226	Interstitial cystitis with Hunners ulcer
28	Systemic amyloidosis
70	Spinal stenosis
84	Sarcoidosis
8	Huntington disease
34	Neurofibromatosis
51	Scleroderma
96	Crohn disease
2	Amyotrophic lateral sclerosis
46	Malignant rheumatoid arthritis